{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-009661","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2023-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.841952+00:00","generated_at":"2026-06-13T03:12:42.271078+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"ENDRA Life Sciences adjourns annual meeting to Aug. 9 due to lack of quorum","bullets":["Annual meeting reconvened July 25, 2023 and again adjourned for lack of quorum; new date Aug. 9, 2023 at 10:00 AM ET.","Stockholders who already voted need not recast; proxies remain valid unless revoked.","Voting deadline extended to Aug. 8, 2023 at 11:59 PM ET; company continues solicitation.","Meeting was first commenced and adjourned on July 6, 2023 for same reason."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-009661","json":"https://secwatch.observer/filing/0001654954-23-009661.json","markdown":"https://secwatch.observer/filing/0001654954-23-009661.md","text":"https://secwatch.observer/filing/0001654954-23-009661.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000165495423009661/0001654954-23-009661-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000165495423009661/ndra_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T03:12:42.271078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}